Treatment suitability and results vary by individual
Most patients notice appetite reduction within the first 12 weeks of starting GLP-1 medication
Many people saw good average weight loss
2023 DOI: 10.1016/S0140-6736(23)01053-X PMID: 37385280 Read on PubMed Diabetes, Obesity and Metabolism The novel GIP, GLP-1 and glucagon receptor agonist retatrutide delays gastric emptying Urva S, Quinlan T, Landry J, et al
How has it affected your migraine headaches
Others may experience intermittent symptoms depending on meal size, composition, and individual sensitivity to delayed gastric emptying., Clinical note: In real-world clinical practice, acute episodes triggered by a specific meal often resolve within 24 hours as gastric emptying progresses